These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6091380)

  • 41. Transcription regulates oxolinic acid-induced DNA gyrase cleavage at specific sites on the E. coli chromosome.
    Condemine G; Smith CL
    Nucleic Acids Res; 1990 Dec; 18(24):7389-96. PubMed ID: 2175434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gyrase inhibitors and intracellular DNA supercoiling.
    Franco RJ; Drlica K
    Biochem Soc Trans; 1986 Apr; 14(2):499-501. PubMed ID: 3011555
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
    Hueso-Falcón I; Amesty Á; Anaissi-Afonso L; Lorenzo-Castrillejo I; Machín F; Estévez-Braun A
    Bioorg Med Chem Lett; 2017 Feb; 27(3):484-489. PubMed ID: 28040393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological activity studies of 3-arylaminomethyl-7H-6-(6 substituted-3-coumarino)-S-triazolo-[3,4-b][1,3,4]thiadiazines.
    Kalluraya B; Vishwanath P
    Boll Chim Farm; 1998 May; 137(5):169-72. PubMed ID: 9689904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
    Fonseca A; Reis J; Silva T; Matos MJ; Bagetta D; Ortuso F; Alcaro S; Uriarte E; Borges F
    J Med Chem; 2017 Aug; 60(16):7206-7212. PubMed ID: 28753307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues.
    Chiang CC; Mouscadet JF; Tsai HJ; Liu CT; Hsu LY
    Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1740-3. PubMed ID: 18057750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA gyrase as a drug target.
    Maxwell A
    Biochem Soc Trans; 1999 Feb; 27(2):48-53. PubMed ID: 10093705
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis and in vitro activity of new semi-synthetic coumermycin analogs: chemical modification at the C-3 amide.
    Ueda Y; Chuang JM; Crast LB; Partyka RA
    J Antibiot (Tokyo); 1989 Sep; 42(9):1379-92. PubMed ID: 2793593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein.
    Gellert M; Fisher LM; O'Dea MH
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6289-93. PubMed ID: 230505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
    Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
    Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topoisomerization of plasmid DNA in Escherichia coli infected with bacteriophage T4.
    Albright LM; Geiduschek EP
    J Mol Biol; 1986 Aug; 190(3):329-41. PubMed ID: 3023639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semisynthetic coumermycins. VI. Preparation and properties of 3-(3-aryl- and 3-aralkyl-4-hydroxybenzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy]coumarins.
    Schmitz H; Godfrey JC
    J Antibiot (Tokyo); 1970 Oct; 23(10):497-501. PubMed ID: 5482760
    [No Abstract]   [Full Text] [Related]  

  • 54. The Chromenopyridine Scaffold: A Privileged Platform in Drug Design.
    Pedroso de Lima F; Costa M; Sousa A; Proença MF
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relation of conformation and antalgic activity of 2-aryl-dihydrothienocoumarins].
    Robert JF; Ombetta JE; Xicluna A; Panouse JJ
    Ann Pharm Fr; 1988; 46(4):273-81. PubMed ID: 3250312
    [No Abstract]   [Full Text] [Related]  

  • 56. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase.
    Portolani M; Pietrosemoli P; Cermelli C; Mannini-Palenzona A; Grossi MP; Paolini L; Barbanti-Brodano G
    Antiviral Res; 1988 Apr; 9(3):205-18. PubMed ID: 2840850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.
    Xu ZQ; Buckheit RW; Stup TL; Flavin MT; Khilevich A; Rizzo JD; Lin L; Zembower DE
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2179-84. PubMed ID: 9873509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of 2-(substituted phenyl)-3-[5-(2-oxo-2H-chromen-3-yl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-ones with antimicrobial activity.
    Bhat MA; Al-Omar MA; Siddiqui N
    Acta Pol Pharm; 2011; 68(2):295-9. PubMed ID: 21485305
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis and biological evaluation of α-methylidene-δ-lactones with 3,4-dihydrocoumarin skeleton.
    Modranka J; Albrecht A; Jakubowski R; Krawczyk H; Różalski M; Krajewska U; Janecka A; Wyrębska A; Różalska B; Janecki T
    Bioorg Med Chem; 2012 Aug; 20(16):5017-26. PubMed ID: 22789709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase in synthesis and stability of sigma 32 on treatment with inhibitors of DNA gyrase in Escherichia coli.
    Mizushima T; Ohtsuka Y; Mori H; Miki T; Sekimizu K
    Mol Gen Genet; 1996 Dec; 253(3):297-302. PubMed ID: 9003316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.